AU767587B2 - Nucleic acid sequences for detecting genetic markers for cancer in a biological sample - Google Patents

Nucleic acid sequences for detecting genetic markers for cancer in a biological sample Download PDF

Info

Publication number
AU767587B2
AU767587B2 AU34755/00A AU3475500A AU767587B2 AU 767587 B2 AU767587 B2 AU 767587B2 AU 34755/00 A AU34755/00 A AU 34755/00A AU 3475500 A AU3475500 A AU 3475500A AU 767587 B2 AU767587 B2 AU 767587B2
Authority
AU
Australia
Prior art keywords
seq
psa
oligonucleotide
sequence
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU34755/00A
Other languages
English (en)
Other versions
AU3475500A (en
Inventor
Thomas J. Clark Jr.
Richard C. Harvey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gen Probe Inc
Original Assignee
Gen Probe Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Probe Inc filed Critical Gen Probe Inc
Publication of AU3475500A publication Critical patent/AU3475500A/en
Application granted granted Critical
Publication of AU767587B2 publication Critical patent/AU767587B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU34755/00A 1999-01-28 2000-01-28 Nucleic acid sequences for detecting genetic markers for cancer in a biological sample Ceased AU767587B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11764099P 1999-01-28 1999-01-28
US60/117640 1999-01-28
PCT/US2000/002270 WO2000044940A2 (en) 1999-01-28 2000-01-28 Nucleic acid sequences for detecting genetic markers for cancer in a biological sample

Publications (2)

Publication Number Publication Date
AU3475500A AU3475500A (en) 2000-08-18
AU767587B2 true AU767587B2 (en) 2003-11-20

Family

ID=22374015

Family Applications (1)

Application Number Title Priority Date Filing Date
AU34755/00A Ceased AU767587B2 (en) 1999-01-28 2000-01-28 Nucleic acid sequences for detecting genetic markers for cancer in a biological sample

Country Status (6)

Country Link
US (5) US6551778B1 (cg-RX-API-DMAC10.html)
EP (1) EP1151142A2 (cg-RX-API-DMAC10.html)
JP (1) JP4495349B2 (cg-RX-API-DMAC10.html)
AU (1) AU767587B2 (cg-RX-API-DMAC10.html)
CA (1) CA2360073C (cg-RX-API-DMAC10.html)
WO (1) WO2000044940A2 (cg-RX-API-DMAC10.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7019498A (en) * 1997-04-10 1998-10-30 Diagnocure Inc. Pca3, pca3 genes, and methods of use
JP4495349B2 (ja) * 1999-01-28 2010-07-07 ジェン−プローブ・インコーポレーテッド 癌の遺伝マーカーを生物学的サンプルにおいて検出するための核酸配列
DK1222266T3 (da) * 1999-09-29 2006-07-10 Diagnocure Inc PCA3-messenger-RNA i benigne og maligne prostatavæv
AU2002217991A1 (en) * 2000-11-21 2002-06-03 Diadexus, Inc. Compositions and methods relating to prostate specific genes and proteins
WO2003068918A2 (en) * 2002-02-11 2003-08-21 Auburn University High-sensitivity real-time polymerase chain reaction for detection of nucleic acids
JP4824540B2 (ja) * 2003-02-07 2011-11-30 ダイアノキュアー インク． サンプル中の前立腺癌を検出する方法
CN100577815C (zh) * 2003-05-01 2010-01-06 维里德克斯有限责任公司 手术中的淋巴结检测
CA2491067A1 (en) 2004-12-24 2006-06-24 Stichting Katholieke Universiteit Mrna rations in urinary sediments and/or urine as a prognostic marker for prostate cancer
US20070130694A1 (en) * 2005-12-12 2007-06-14 Michaels Emily W Textile surface modification composition
EP3095873B1 (en) 2006-12-21 2018-04-18 Gen-Probe Incorporated Methods and compositions for nucleic acid amplification
US20110091883A1 (en) * 2009-02-18 2011-04-21 Helicos Biosciences Corporation Methods for analyzing minute cellular nucleic acids
CN102414554B (zh) * 2009-04-22 2014-11-26 威斯康星校友研究基金会 采用液晶的分析物检测
CA2766391C (en) 2009-07-01 2021-04-20 Gen-Probe Incorporated Methods and compositions for multiplex nucleic acid amplification
CA3081061C (en) * 2010-07-27 2023-01-03 Genomic Health, Inc. Method for using expression of klk2 to determine prognosis of prostate cancer
CA2811333C (en) 2010-09-16 2020-05-12 Gen-Probe Incorporated Capture probes immobilizable via l-nucleotide tail
US9255293B2 (en) 2010-11-01 2016-02-09 Gen-Probe Incorporated Integrated capture and amplification of target nucleic acid for sequencing
AU2013205603B2 (en) 2012-02-01 2016-03-17 Gen-Probe Incorporated Asymmetric hairpin target capture oligomers
JP6308954B2 (ja) 2012-03-05 2018-04-11 オサケユキテュア・アークティック・パートナーズ・アクチボラゲットＯｙ Ａｒｃｔｉｃ Ｐａｒｔｎｅｒｓ Ａｂ 前立腺癌のリスク及び前立腺容積を予測する方法及び装置
CN114740202A (zh) 2014-03-28 2022-07-12 欧普科诊断有限责任公司 与前列腺癌的诊断有关的组合物和方法
US12326453B2 (en) 2014-03-28 2025-06-10 Opko Diagnostics, Llc Compositions and methods for active surveillance of prostate cancer
EP3253800B1 (en) 2015-03-27 2021-03-03 Opko Diagnostics, LLC Prostate antigen standards and uses thereof
CA2982262A1 (en) 2015-04-29 2016-11-03 Opko Diagnostics, Llc Compositions and methods for active surveillance of prostate cancer
EP3448998B1 (en) * 2016-04-27 2020-06-03 Gen-Probe Incorporated Blood cell lysis reagent
CN111518170A (zh) * 2020-05-09 2020-08-11 新乡医学院 基于fret的psa荧光探针、制备方法及其应用
CA3254118A1 (en) 2022-03-15 2023-09-21 Diagenode S.A. DETECTION OF THE METHYLATION STATE OF A DNA SAMPLE

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996021042A2 (en) * 1995-01-04 1996-07-11 Trustees Of Boston University Primers for the pcr amplification of metastatic sequences
WO1996026272A1 (en) * 1995-02-24 1996-08-29 Sloan-Kettering Institute For Cancer Research Prostate-specific membrane antigen and uses thereof
US5858673A (en) * 1996-06-24 1999-01-12 Charlotte-Mecklenburg Hospital Authority Method for detecting prostate cells

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3725010A (en) * 1971-08-23 1973-04-03 Beckman Instruments Inc Apparatus for automatically performing chemical processes
US5283174A (en) 1987-09-21 1994-02-01 Gen-Probe, Incorporated Homogenous protection assay
CA2020958C (en) 1989-07-11 2005-01-11 Daniel L. Kacian Nucleic acid sequence amplification methods
US5851764A (en) * 1990-10-25 1998-12-22 The Trustees Of Columbia University In The City Of New York Human prostate tumor inducing gene-1 and uses thereof
AU662906B2 (en) 1991-06-26 1995-09-21 F. Hoffmann-La Roche Ag Methods for detection of carcinoma metastases by nucleic acid amplification
WO1993022461A1 (en) 1992-05-06 1993-11-11 Gen-Probe Incorporated Nucleic acid sequence amplification method, composition and kit
US5786148A (en) 1996-11-05 1998-07-28 Incyte Pharmaceuticals, Inc. Polynucleotides encoding a novel prostate-specific kallikrein
US5674682A (en) * 1992-10-29 1997-10-07 Thomas Jefferson University Nucleic acid primers for detecting micrometastasis of prostate cancer
EP0667920B1 (en) 1992-10-29 2003-01-15 Thomas Jefferson University Methods of detecting micrometastasis of prostate cancer
EP1757695A3 (en) 1992-11-05 2008-02-27 Sloan Kettering Institute For Cancer Research Prostate-specific membrane antigen
US6103237A (en) * 1993-07-22 2000-08-15 Hybritech Incorporated Stable variant hK2 polypeptide
US5516639A (en) 1993-07-22 1996-05-14 Mayo Foundation For Medical Education And Research Antibodies specific for human prostate glandular kallkrein
US6569432B1 (en) * 1995-02-24 2003-05-27 Sloan-Kettering Institute For Cancer Research Prostate-specific membrane antigen and uses thereof
FR2714062B1 (fr) * 1993-12-22 1996-02-16 Bio Merieux Promoteur modifié pour ARN polymérase, sa préparation et ses applications.
US5599677A (en) 1993-12-29 1997-02-04 Abbott Laboratories Immunoassays for prostate specific antigen
US5976794A (en) * 1994-04-15 1999-11-02 The Trustees Of Columbia University In The City Of New York Method for molecular staging of prostate cancer
AU699748B2 (en) * 1994-05-10 1998-12-10 Hybritech Incorporated Recombinant HK2 polypeptide
US5698402A (en) 1995-02-23 1997-12-16 Dianon Systems, Inc. Methods for diagnosing benign prostatic hyperplasia
US5773292A (en) 1995-06-05 1998-06-30 Cornell University Antibodies binding portions, and probes recognizing an antigen of prostate epithelial cells but not antigens circulating in the blood
GB2302874B (en) * 1995-06-29 1999-11-10 Orion Yhtymae Oy Novel proteins
WO1997007242A1 (en) 1995-08-16 1997-02-27 Steven Lehrer Method for detecting circulating breast cancer cells
US5710007A (en) 1995-09-29 1998-01-20 Luderer; Albert A. Methods for diagnosing prostatic adenocarcinoma
US5861248A (en) 1996-03-29 1999-01-19 Urocor, Inc. Biomarkers for detection of prostate cancer
JP2000508171A (ja) * 1996-04-05 2000-07-04 ザ・ジョンズ・ホプキンス・ユニバーシティ・スクール・オブ・メディシン 希少細胞の富化方法
ZA973231B (en) 1996-04-16 1997-11-25 Smithkline Beecham Corp A method for detection of prostate specific antigen used in monitoring and diagnosis of prostate cancer.
US6117635A (en) 1996-07-16 2000-09-12 Intergen Company Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon
WO1998021365A2 (en) 1996-11-14 1998-05-22 Mayo Foundation For Medical Education And Research Method for detection of metastatic prostate cancer
US6479263B1 (en) * 1996-11-14 2002-11-12 Baylor College Of Medicine Method for detection of micrometastatic prostate cancer
CA2218754A1 (en) 1996-11-15 1998-05-15 Eli Lilly And Company Recombinant psa expression vectors and assays using the same
US6100444A (en) 1997-02-11 2000-08-08 University Of Rochester Medical Center Prostate specific regulatory nucleic acid sequences and transgenic non-human animals expressing prostate specific antigen
US6620922B1 (en) * 1997-02-25 2003-09-16 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US7033827B2 (en) * 1997-02-25 2006-04-25 Corixa Corporation Prostate-specific polynucleotide compositions
US6759515B1 (en) * 1997-02-25 2004-07-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6630305B1 (en) * 1999-11-12 2003-10-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
AU6551398A (en) 1997-03-11 1998-09-29 Anna C. Ferrari Method of detecting prostate cancer metastasis
EP0972084A2 (en) * 1997-04-11 2000-01-19 Micromet Gesellschaft für Biomedizinische Forschung mbH Primers and methods for the detection of disseminated tumor cells
WO1998049323A1 (en) 1997-04-30 1998-11-05 Hybritech Incorporated Forms of prostate specific antigen and methods for their detection
AU8259798A (en) * 1997-06-20 1999-01-04 George G Klee Method for detection of breast cancer
US5817798A (en) * 1997-09-17 1998-10-06 Abbott Laboratories Rapid RNA isolation procedure in the presence of a transition metal ion
US8101349B2 (en) * 1997-12-23 2012-01-24 Novartis Vaccines And Diagnostics, Inc. Gene products differentially expressed in cancerous cells and their methods of use II
US20030215803A1 (en) * 2000-12-07 2003-11-20 Garcia Pablo Dominguez Human genes and gene expression products isolated from human prostate
JP2000069969A (ja) 1998-08-28 2000-03-07 Hitachi Chem Co Ltd プライマーＤＮＡ及びこれを用いる前立腺特異抗原をコードするｍＲＮＡの検出方法
JP4495349B2 (ja) * 1999-01-28 2010-07-07 ジェン−プローブ・インコーポレーテッド 癌の遺伝マーカーを生物学的サンプルにおいて検出するための核酸配列
EP1159429A2 (en) * 1999-02-18 2001-12-05 Compugen Ltd. Psa and klk-2 splicing variants
CA2366087A1 (en) 1999-03-11 2000-09-14 Mount Sinai Hospital Sialic acid-binding ig-like lectin (siglec) gene; ob-binding protein like (ob-bpl)
AU4484400A (en) 1999-04-23 2000-11-10 University Of Washington Prostate-specific polynucleotides, polypeptides and their methods of use
WO2000071711A2 (en) 1999-05-20 2000-11-30 Fahri Saatcioglu Differentially expressed genes in prostate cancer
AU2001241541A1 (en) * 2000-02-17 2001-08-27 Millennium Predictive Medicine, Inc. Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of human prostate cancer
CN100422323C (zh) 2000-04-07 2008-10-01 荣研化学株式会社 使用双链核酸为模板扩增核酸的方法
WO2001076622A2 (en) 2000-04-10 2001-10-18 Aventis Pasteur Limited Immunogenic peptides derived from prostate-specific antigen (psa) and uses thereof
ATE325871T1 (de) 2000-05-01 2006-06-15 Eiken Chemical Verfahren zur erkennung des produkts einer nukleinsäuresynthetisierungsreaktion
ATE524560T1 (de) * 2001-06-18 2011-09-15 Eiken Chemical Effizientes nachweisverfahren für doppelsträngige nukleinsäure
JP2005519606A (ja) * 2002-03-14 2005-07-07 エグゾニ・テラピューティック・ソシエテ・アノニム ヒトカリクレイン−２及びカリクレイン−３のバリアント並びにそれらの使用
US7348142B2 (en) * 2002-03-29 2008-03-25 Veridex, Lcc Cancer diagnostic panel
JP4824540B2 (ja) * 2003-02-07 2011-11-30 ダイアノキュアー インク． サンプル中の前立腺癌を検出する方法
US20040223885A1 (en) * 2003-05-06 2004-11-11 Keen Randy E. Apparatus for the automated synthesis of polynucleotides
US20060008468A1 (en) * 2004-06-17 2006-01-12 Chih-Sheng Chiang Combinations of tumor-associated antigens in diagnostics for various types of cancers

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996021042A2 (en) * 1995-01-04 1996-07-11 Trustees Of Boston University Primers for the pcr amplification of metastatic sequences
WO1996026272A1 (en) * 1995-02-24 1996-08-29 Sloan-Kettering Institute For Cancer Research Prostate-specific membrane antigen and uses thereof
US5858673A (en) * 1996-06-24 1999-01-12 Charlotte-Mecklenburg Hospital Authority Method for detecting prostate cells

Also Published As

Publication number Publication date
US20090035773A1 (en) 2009-02-05
CA2360073C (en) 2011-01-18
WO2000044940A3 (en) 2000-12-07
US6811985B2 (en) 2004-11-02
EP1151142A2 (en) 2001-11-07
CA2360073A1 (en) 2000-08-03
US20080026398A1 (en) 2008-01-31
US6551778B1 (en) 2003-04-22
US20030104448A1 (en) 2003-06-05
US7267956B2 (en) 2007-09-11
JP2002535014A (ja) 2002-10-22
AU3475500A (en) 2000-08-18
WO2000044940A2 (en) 2000-08-03
JP4495349B2 (ja) 2010-07-07
US20050118630A1 (en) 2005-06-02

Similar Documents

Publication Publication Date Title
US20080026398A1 (en) Nucleic acid sequences for detecting genetic markers for cancer in a biological sample
US11104958B2 (en) Method to detect prostate cancer in a sample
JP4944041B2 (ja) 前立腺癌の予後判定用マーカー及び／又はテラノスティックマーカーとなる、尿沈渣及び／又は尿のｍＲＮＡ比
JP4741481B2 (ja) Ｐｃａ３遺伝子に基づく、前立腺癌の検知のための特異的な方法およびそれを実施するためのキット
EP0760006A1 (en) Method for molecular staging of prostate cancer
JP2006510870A (ja) 癌腫の分子診断および予後
WO1998010098A1 (en) Use of prostate tumor inducing gene for detection of cancer cells
HK1148315B (en) Mrna ratios in urinary sediments and/or urine as a prognostic and/or theranostic marker for prostate cancer

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)